214 related articles for article (PubMed ID: 9192303)
41. The long QT syndrome: new diagnostic and therapeutic approach in the era of molecular biology.
Priori SG; Cantù F; Schwartz PJ
Schweiz Med Wochenschr; 1996 Oct; 126(41):1727-31. PubMed ID: 8893413
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of HERG K+ current and prolongation of the guinea-pig ventricular action potential by 4-aminopyridine.
Ridley JM; Milnes JT; Zhang YH; Witchel HJ; Hancox JC
J Physiol; 2003 Jun; 549(Pt 3):667-72. PubMed ID: 12740430
[TBL] [Abstract][Full Text] [Related]
43. Sulfonylureas blockade of neural and cardiac HERG channels.
Rosati B; Rocchetti M; Zaza A; Wanke E
FEBS Lett; 1998 Nov; 440(1-2):125-30. PubMed ID: 9862440
[TBL] [Abstract][Full Text] [Related]
44. Long-term modulation of HERG channel gating in hypoxia.
Fontana L; D'Amico M; Crociani O; Biagiotti T; Solazzo M; Rosati B; Arcangeli A; Wanke E; Olivotto M
Biochem Biophys Res Commun; 2001 Sep; 286(5):857-62. PubMed ID: 11527377
[TBL] [Abstract][Full Text] [Related]
45. Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.
Milnes JT; Crociani O; Arcangeli A; Hancox JC; Witchel HJ
Br J Pharmacol; 2003 Jul; 139(5):887-98. PubMed ID: 12839862
[TBL] [Abstract][Full Text] [Related]
46. HERG K(+) currents in human prolactin-secreting adenoma cells.
Bauer CK; Wulfsen I; Schäfer R; Glassmeier G; Wimmers S; Flitsch J; Lüdecke DK; Schwarz JR
Pflugers Arch; 2003 Feb; 445(5):589-600. PubMed ID: 12634931
[TBL] [Abstract][Full Text] [Related]
47. Dynamic control of deactivation gating by a soluble amino-terminal domain in HERG K(+) channels.
Wang J; Myers CD; Robertson GA
J Gen Physiol; 2000 Jun; 115(6):749-58. PubMed ID: 10828248
[TBL] [Abstract][Full Text] [Related]
48. The antihistamine fexofenadine does not affect I(Kr) currents in a case report of drug-induced cardiac arrhythmia.
Scherer CR; Lerche C; Decher N; Dennis AT; Maier P; Ficker E; Busch AE; Wollnik B; Steinmeyer K
Br J Pharmacol; 2002 Nov; 137(6):892-900. PubMed ID: 12411421
[TBL] [Abstract][Full Text] [Related]
49. Modulation of human erg K+ channel gating by activation of a G protein-coupled receptor and protein kinase C.
Barros F; Gomez-Varela D; Viloria CG; Palomero T; Giráldez T; de la Peña P
J Physiol; 1998 Sep; 511 ( Pt 2)(Pt 2):333-46. PubMed ID: 9706014
[TBL] [Abstract][Full Text] [Related]
50. Gastrointestinal prokinetic drugs have different affinity for the human cardiac human ether-à-gogo K(+) channel.
Potet F; Bouyssou T; Escande D; Baró I
J Pharmacol Exp Ther; 2001 Dec; 299(3):1007-12. PubMed ID: 11714889
[TBL] [Abstract][Full Text] [Related]
51. Blockade of HERG channels expressed in Xenopus oocytes by external H+.
Jo SH; Youm JB; Kim I; Lee CO; Earm YE; Ho WK
Pflugers Arch; 1999 Jun; 438(1):23-9. PubMed ID: 10370083
[TBL] [Abstract][Full Text] [Related]
52. Human ether-a-gogo related gene (HERG) K+ channels as pharmacological targets: present and future implications.
Taglialatela M; Castaldo P; Pannaccione A; Giorgio G; Annunziato L
Biochem Pharmacol; 1998 Jun; 55(11):1741-6. PubMed ID: 9714291
[TBL] [Abstract][Full Text] [Related]
53. Modulation of HERG potassium channel properties by external pH.
Bérubé J; Chahine M; Daleau P
Pflugers Arch; 1999 Aug; 438(3):419-22. PubMed ID: 10398876
[TBL] [Abstract][Full Text] [Related]
54. HERG- and IRK-like inward rectifier currents are sequentially expressed during neuronal development of neural crest cells and their derivatives.
Arcangeli A; Rosati B; Cherubini A; Crociani O; Fontana L; Ziller C; Wanke E; Olivotto M
Eur J Neurosci; 1997 Dec; 9(12):2596-604. PubMed ID: 9517465
[TBL] [Abstract][Full Text] [Related]
55. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents.
Katchman AN; McGroary KA; Kilborn MJ; Kornick CA; Manfredi PL; Woosley RL; Ebert SN
J Pharmacol Exp Ther; 2002 Nov; 303(2):688-94. PubMed ID: 12388652
[TBL] [Abstract][Full Text] [Related]
56. Biophysical properties and molecular basis of cardiac rapid and slow delayed rectifier potassium channels.
Mitcheson JS; Sanguinetti MC
Cell Physiol Biochem; 1999; 9(4-5):201-16. PubMed ID: 10575198
[TBL] [Abstract][Full Text] [Related]
57. Interactions of the narcotic l-alpha-acetylmethadol with human cardiac K+ channels.
Kang J; Chen XL; Wang H; Rampe D
Eur J Pharmacol; 2003 Jan; 458(1-2):25-9. PubMed ID: 12498903
[TBL] [Abstract][Full Text] [Related]
58. Demonstration of an inwardly rectifying K+ current component modulated by thyrotropin-releasing hormone and caffeine in GH3 rat anterior pituitary cells.
Barros F; del Camino D; Pardo LA; Palomero T; Giráldez T; de la Peña P
Pflugers Arch; 1997 Dec; 435(1):119-29. PubMed ID: 9359911
[TBL] [Abstract][Full Text] [Related]
59. Regulation of the cardiac repolarizing HERG potassium channel by protein kinase A.
Kiehn J
Trends Cardiovasc Med; 2000 Jul; 10(5):205-9. PubMed ID: 11282296
[TBL] [Abstract][Full Text] [Related]
60. Physiology of EAG K+ channels.
Bauer CK; Schwarz JR
J Membr Biol; 2001 Jul; 182(1):1-15. PubMed ID: 11426295
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
